mefenamic acid has been researched along with propranolol in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hornabrook, RW; Johnson, RH; Lambie, DG | 1 |
| Dinnendahl, V; Peters, HD; Schönhöfer, PS | 1 |
| Jones, OA; Lester, JN; Voulvoulis, N | 1 |
| Currie, F; Goodacre, R; Patel, SA; Thakker, N | 1 |
1 review(s) available for mefenamic acid and propranolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for mefenamic acid and propranolol
| Article | Year |
|---|---|
Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis.
Topics: Adult; Aged; Clinical Trials as Topic; Depression; Female; Gastrointestinal Diseases; Humans; Male; Mefenamic Acid; Middle Aged; Migraine Disorders; Propranolol | 1986 |
10 other study(ies) available for mefenamic acid and propranolol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Effects of antilipolytic drugs on cyclic 3',5'-AMP dependent protein kinase.
Topics: Adipose Tissue; Animals; Cattle; Chloroquine; Cyclic AMP; Dose-Response Relationship, Drug; Flufenamic Acid; In Vitro Techniques; Insulin; Lipid Metabolism; Mefenamic Acid; Muscles; Nicotinic Acids; Norepinephrine; Phentolamine; Phenylbutazone; Phosphotransferases; Propranolol; Prostaglandins; Protein Kinase Inhibitors; Protein Kinases; Pyrazoles; Theophylline | 1973 |
The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment.
Topics: Acetaminophen; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; England; Environmental Pollutants; Gas Chromatography-Mass Spectrometry; Ibuprofen; Mefenamic Acid; Pharmaceutical Preparations; Propranolol; Sewage; Waste Management | 2007 |
Spatial metabolic fingerprinting using FT-IR spectroscopy: investigating abiotic stresses on Micrasterias hardyi.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Eukaryota; Mefenamic Acid; Metoprolol; Propranolol; Spectroscopy, Fourier Transform Infrared; Toxicity Tests, Acute; Water Pollutants, Chemical | 2008 |